Gemcitabine Intravesical System
(jem-SY-tuh-been IN-truh-VEH-sih-kul SIS-tehm)
This page contains brief information about the gemcitabine intravesical system and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s)
Inlexzo
FDA Approved
Yes
FDA label information for this drug is available at DailyMed.
Use in Cancer
Gemcitabine intravesical system is approved to treat:
- Non-muscle–invasive bladder cancer with carcinoma in situ. It is used in adults whose cancer does not respond to treatment with bacillus Calmette-Guérin (BCG).
More About Gemcitabine Intravesical System
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
MedlinePlus Information on Gemcitabine Intravesical System - A lay language summary of important information about this drug.
Clinical Trials Accepting Patients
Find Clinical Trials for Gemcitabine Intravesical System - Check for trials from NCI's list of cancer clinical trials now accepting patients.